CoChat

Liver alanine catabolism promotes skeletal muscle atrophy and hyperglycaemia in type 2 diabetes

Open access
Okun, Jürgen G., Rusu, Patricia M., Chan, Andrea Y., Wu, Yuqin, Yap, Yann W., Sharkie, Thomas, Schumacher, Jonas, Schmidt, Kathrin V., Roberts-Thomson, Katherine M., Russell, Ryan D., Zota, Annika, Hille, Susanne, Jungmann, Andreas, Maggi, Ludovico, Lee, Young, Blüher, Matthias, Herzig, Stephan, Keske, Michelle A., Heikenwalder, Mathias, Müller, Oliver J., Rose, Adam J. · 2021 · Nature Metabolism
Cited by 116

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Both obesity and sarcopenia are frequently associated in ageing, and together may promote the progression of related conditions such as diabetes and frailty. However, little is known about the pathophysiological mechanisms underpinning this association. Here we show that systemic alanine metabolism is linked to glycaemic control. We find that expression of alanine aminotransferases is increased in the liver in mice with obesity and diabetes, as well as in humans with type 2 diabetes. Hepatocyte-selective silencing of both alanine aminotransferase enzymes in mice with obesity and diabetes retards hyperglycaemia and reverses skeletal muscle atrophy through restoration of skeletal muscle protein synthesis. Mechanistically, liver alanine catabolism driven by chronic glucocorticoid and glucagon signalling promotes hyperglycaemia and skeletal muscle wasting. We further provide evidence for amino acid–induced metabolic cross-talk between the liver and skeletal muscle in ex vivo experiments. Taken together, we reveal a metabolic inter-tissue cross-talk that links skeletal muscle atrophy and hyperglycaemia in type 2 diabetes. Elevated hepatic alanine catabolism is shown to promote hyperglycaemia and reduce skeletal muscle protein synthesis, thereby linking sarcopenia with hyperglycaemia in the context of type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42255-021-00369-9

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 116

Metadata

Authors
Okun, J. G., Rusu, P. M., Chan, A. Y., Wu, Y., Yap, Y. W., Sharkie, T., Schumacher, J., Schmidt, K. V., Roberts-Thomson, K. M., Russell, R. D., Zota, A., Hille, S., Jungmann, A., Maggi, L., Lee, Y., Blüher, M., Herzig, S., Keske, M. A., Heikenwalder, M., Müller, O. J., & Rose, A. J.
Venue
Nature Metabolism
Published
2021-03-18
Volume
3
Issue
3
Pages
394-409
ISSN
2522-5812 (ISSN-L)
OpenAlex
W3138014196
Cited by
116
References
18
FWCI
5.57
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liver alanine catabolism promotes skeletal muscle atrophy and hyperglycaemia in type 2 diabetes. https://app.cochat.ai/papers/10.1038/s42255-021-00369-9
The paper
Okun, J. G., Rusu, P. M., Chan, A. Y., Wu, Y., Yap, Y. W., Sharkie, T., Schumacher, J., Schmidt, K. V., Roberts-Thomson, K. M., Russell, R. D., Zota, A., Hille, S., Jungmann, A., Maggi, L., Lee, Y., Blüher, M., Herzig, S., Keske, M. A., Heikenwalder, M., . . . Rose, A. J. (2021). Liver alanine catabolism promotes skeletal muscle atrophy and hyperglycaemia in type 2 diabetes. Nature Metabolism. https://doi.org/10.1038/s42255-021-00369-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.